These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 11494290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Triploidy identified through second-trimester serum screening.
    Huang T, Alberman E, Wald N, Summers AM.
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [Abstract] [Full Text] [Related]

  • 4. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
    Jaques AM, Halliday JL, Francis I, Bonacquisto L, Forbes R, Cronin A, Sheffield LJ.
    BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
    [Abstract] [Full Text] [Related]

  • 5. First-trimester combined screening for Down syndrome and other fetal anomalies.
    O'Leary P, Breheny N, Dickinson JE, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R.
    Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
    [Abstract] [Full Text] [Related]

  • 6. Down syndrome prevention program in a population with an older maternal age.
    Shohat M, Legum C, Romem Y, Borochowitz Z, Bach G, Goldman B.
    Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
    [Abstract] [Full Text] [Related]

  • 7. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ, Dickinson JE, O'Leary P, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R.
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [Abstract] [Full Text] [Related]

  • 8. Antenatal screening for Down syndrome.
    Wald NJ.
    Prog Clin Biol Res; 1995 Dec; 393():27-42. PubMed ID: 8545455
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
    Huang T, Owolabi T, Summers AM, Meier C, Wyatt PR.
    Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
    Hogge WA, Fraer L, Melegari T.
    Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881
    [Abstract] [Full Text] [Related]

  • 19. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR, Cocciolone R, Haan EA, Wilkinson C, Scott H, Sage L, Bird R, Hutchinson R, Chan A.
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.